Update on nutritional supplementation with branched-chain amino acids

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 8, Issue 1, 2005, Pages 83-87

  Bianchi, Giampaolo ^a   Marzocchi, Rebecca ^a   Agostini, Federica ^a   Marchesini, Giulio ^a,b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Amino acids; Neurotransmitter; Nitrogen balance; Protein catabolism

Indexed keywords

BRANCHED CHAIN AMINO ACID;

AMINO ACID TRANSPORT; BED REST; BLOOD BRAIN BARRIER; DIET SUPPLEMENTATION; HEART FAILURE; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER CIRRHOSIS; LIVER DISEASE; MANIA; MUSCLE FUNCTION; MUSCLE MASS; MUSCLE METABOLISM; NEUROTRANSMISSION; NITROGEN METABOLISM; OBESITY; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN SYNTHESIS; REVIEW; SPACE FLIGHT; SPINOCEREBELLAR DEGENERATION; TARDIVE DYSKINESIA; WEIGHT REDUCTION;

AMINO ACIDS, BRANCHED-CHAIN; BRAIN; DIETARY SUPPLEMENTS; GLUCONEOGENESIS; HUMANS; LIVER DISEASES; MUSCLE, SKELETAL; NEUROTRANSMITTER AGENTS; OBESITY;

EID: 13444269149     PISSN: 13631950     EISSN: None     Source Type: Journal    
DOI: 10.1097/00075197-200501000-00013     Document Type: Review

References (36)

1. Kimball SR, Jefferson LS. Regulation of protein synthesis by branched-chain amino acids. Curr Opin Clin Nutr Metab Care 2001; 4:39-43.
2. De Lorenzo A, Petroni ML, Masala S, et al. Effect of acute and chronic branched-chain amino acids on energy metabolism and muscle performance. Diabetes Nutr Metab 2003; 16:291-297. The study expands current knowledge on the effects of BCAA supply in athletes.
3. Scarnà A, Gijsman HJ, McTavish SF, et al. Effects of a branched-chain amino acid drink in mania. Br J Psychiatry 2003; 182:210-213. Dietary manipulations limiting tyrosine availability may be of value in the treatment of psychiatric conditions. Long-term results are awaited.
4. Layman DK, Shiue H, Sather C, et al. Increased dietary protein modifies glucose and insulin homeostasis in adult women during weight loss. J Nutr 2003; 133:405-410. BCAAs do not significantly stimulate insulin secretion. This effect may be used to reduce glucose excursions during weight-loss programs, at the same time reducing the loss of fat-free mass. Long-term trials are eagerly awaited.
5. Richardson MA, Bevans ML, Read LL, et al. Efficacy of the branched-chain amino acids in the treatment of tardive dyskinesia in men. Am J Psychiatry 2003; 160:1117-1124. A placebo-controlled trial. BCAAs provide a novel approach to treatment of tardive dyskinesia.
6. Stein TP, Donaldson MR, Leskiw MJ, et al. Branched-chain amino acid supplementation during bed rest: effect on recovery. J Appl Physiol 2003; 94:1345-1352. The study raises doubts as to the possible benefits of increased BCAA supply during space flights or in the early post-mission phase, since the amount of nitrogen accreted is not enough to impact protein kinetics.
7. Mori M, Adachi Y, Mori N, et al. Double-blind crossover study of branched-chain amino acid therapy in patients with spinocerebellar degeneration. J Neurol Sci 2002; 195:149-152.
8. Wang XY, Li N, Gu J, et al. The effects of the formula of amino acids enriched BCAA on nutritional support in traumatic patients. World J Gastroenterol 2003; 9:599-602.
9. Aquilani R. Oral amino acid administration in patients with diabetes mellitus: supplementation or metabolic therapy? Am J Cardiol 2004; 93 (Suppl):21A-22A.
10. Als-Nielsen B, Koretz RL, Kjaergard LL, et al. Branched-chain amino acids for hepatic encephalopathy (Cochrane review). In The Cochrane Library, Issue 2. Edited by Chichester, UK: John Wiley & Sons, Ltd, 2004. Meta-analysis of randomized controlled trials on the treatment of hepatic encephalopathy with intravenous and oral BCAAs.
11. Marchesini G, Bianchi G, Merli M, et al. Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial. Gastroenterology 2003; 124:1792-1801. The largest study ever published on oral BCAAs as nutritional supplements in advanced cirrhosis.
12. Poon RT, Yu WC, Fan ST, et al. Long-term oral branched chain amino acids in patients undergoing chemoembolization for hepatocellular carcinoma: a randomized trial. Aliment Pharmacol Ther 2004; 19:779-788. BCAA supplements may be used to reduce morbidity in these poor-risk patients.
13. Fukushima H, Miwa Y, Ida E, et al. Nocturnal branched-chain amino acid administration improves protein metabolism in patients with liver cirrhosis: comparison with daytime administration. J Parenter Enteral Nutr 2003; 27:315-322. The study is in keeping with the evidence that the hypercatabolism of cirrhosis, stimulated by accelerated fasting, may be prevented by frequent meals or by BCAAs.
14. Tietge UJ, Bahr MJ, Manns MP, et al. Plasma amino acids in cirrhosis and after liver transplantation: influence of liver function, hepatic hemodynamics and circulating hormones. Clin Transplant 2002; 16:9-17.
15. Phillips SM, Tipton KD, Ferrando AA, et al. Resistance training reduces the acute exercise-induced increase in muscle protein turnover. Am J Physiol 1999; 276:E118-124.
16. McKenzie S, Phillips SM, Carter SL, et al. Endurance exercise training attenuates leucine oxidation and BCOAD activation during exercise in humans. Am J Physiol Endocrinol Metab 2000; 278:E580-587.
17. Carraro F, Hartl WH, Stuart CA, et al. Whole body and plasma protein synthesis in exercise and recovery in human subjects. Am J Physiol 1990; 258:E821-831.
18. Rennie MJ, Tipton KD. Protein and amino acid metabolism during and after exercise and the effects of nutrition. Annu Rev Nutr 2000; 20:457-483.
19. Forslund AH, El-Khoury AE, Olsson RM, et al. Effect of protein intake and physical activity on 24-h pattern and rate of macronutrient utilization. Am J Physiol 1999; 276:E964-976.
20. Patti ME, Brambilla E, Luzi L, et al. Bidirectional modulation of insulin action by amino acids. J Clin Invest 1998; 101:1519-1529.
21. Anthony JC, Anthony TG, Kimball SR, et al. Signaling pathways involved in translational control of protein synthesis in skeletal muscle by leucine. J Nutr 2001; 131 (Suppl):856S-860S.
22. Anthony TG, Anthony JC, Yoshizawa F, et al. Oral administration of leucine stimulates ribosomal protein mRNA translation but not global rates of protein synthesis in the liver of rats. J Nutr 2001; 131:1171-1176.
23. LeBlanc A, Rowe R, Schneider V, et al. Regional muscle loss after short duration spaceflight. Aviat Space Environ Med 1995; 66:1151-1154.
24. Stein TP, Schluter MD. Plasma amino acids during human spaceflight. Aviat Space Environ Med 1999; 70:250-255.
25. Stuart CA, Shangraw RE, Peters EJ, et al. Effect of dietary protein on bed-rest-related changes in whole-body-protein synthesis. Am J Clin Nutr 1990; 52:509-514.
26. Aquilani R, Opasich C, Verri M, et al. Is nutritional intake adequate in chronic heart failure patients? J Am Coll Cardiol 2003; 42:1218-1223.
27. Young LH, McNulty PH, Morgan C, et al. Myocardial protein turnover in patients with coronary artery disease: effect of branched chain amino acid infusion. J Clin Invest 1991; 87:554-560.
28. Naylor CD, O'Rourke K, Detsky AS, et al. Parenteral nutrition with branched-chain amino acids in hepatic encephalopathy: a meta-analysis. Gastroenterology 1989; 97:1033-1042.
29. Fabbri A, Magrini N, Bianchi G, et al. Overview of randomized clinical trials of oral branched-chain amino acid treatment in chronic hepatic encephalopathy. J Parent Enter Nutr 1996; 20:159-164.
30. Swart GR, Zillikens MC, van Vuure JK, et al. Effect of a late evening meal on nitrogen balance in patients with cirrhosis of the liver. Br Med J 1989; 299:1202-1203.
31. Ishiki Y, Ohnishi H, Muto Y, et al. Direct evidence that hepatocyte growth factor is a hepatotrophic factor for liver regeneration and has a potent antihepatitis effect in vivo. Hepatology 1992; 16:1227-1235.
32. Tomiya T, Inoue Y, Yanase M, et al. Leucine stimulates the secretion of hepatocyte growth factor by hepatic stellate cells. Biochem Biophys Res Commun 2002; 297:1108-1111.
33. Ackenheil M. Neurotransmitters and signal transduction processes in bipolar affective disorders: a synopsis. J Affect Disord 2001; 62:101-111.
34. McTavish SF, McPherson MH, Harmer CJ, et al. Antidopaminergic effects of dietary tyrosine depletion in healthy subjects and patients with manic illness. Br J Psychiatry 2001; 179:356-360.
35. Richardson MA, Haugland G, Pass R, et al. The prevalence of tardive dyskinesia in a mentally retarded population. Psychopharmacol Bull 1986; 22:243-249.
36. Mori N, Adachi Y, Takeshima T, et al. Branched-chain amino acid therapy for spinocerebellar degeneration: a pilot clinical crossover trial. Intern Med 1999; 38:401-406.